VKH
CAPR icon

Virtu KCG Holdings’s Capricor Therapeutics CAPR Stock Holding History

Virtu KCG Holdings’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$149K Buy
17,930
+15,261
+572% +$279K ﹤0.01% 2295
2017
Q1 		$90K Buy
+2,669
New +$74.1K ﹤0.01% 2711
2016
Q3 		– Sell
-1,525
Closed -$60K – 3089
2016
Q2 		$60K Buy
+1,525
New +$53.8K ﹤0.01% 2639

Other funds holding CAPR

CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AA
Apriem Advisors Irvine, California $1.05B AUM 22.09% 1-Year Est. Return
FWM
Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu KCG Holdings's CAPR Position: Q2 2017 in Review

Virtu KCG Holdings increased its Capricor Therapeutics (CAPR) stake by 572% in Q2 2017, buying an estimated $279K and bringing the position to 17,930 shares worth $149K. The position accounts for ﹤0.01% of the portfolio, ranked #2295.

Virtu KCG Holdings first reported a position in CAPR in Q2 2016 and has held it in 3 quarters since. 18 funds tracked by Wall St. Rank hold CAPR as of Q2 2017.

  • Virtu KCG Holdings held 17,930 shares of Capricor Therapeutics worth $149K as of Q2 2017.
  • Virtu KCG Holdings bought 15,261 Capricor Therapeutics shares in Q2 2017, an estimated $279K.
  • Capricor Therapeutics made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2295 holding.
  • Virtu KCG Holdings first reported a position in Capricor Therapeutics in Q2 2016 and has held it in 3 quarters since.
  • 18 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.